- Home
- PDI vs ACLX Comparison
PDI vs ACLX Comparison
Compare PDI & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDI
- ACLX
- Stock Information
- Founded
- PDI 2012
- ACLX 2015
- Country
- PDI United States
- ACLX United States
- Employees
- PDI N/A
- ACLX N/A
- Industry
- PDI Trusts Except Educational Religious and Charitable
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- PDI Finance
- ACLX Health Care
- Exchange
- PDI Nasdaq
- ACLX Nasdaq
- Market Cap
- PDI 6.2B
- ACLX 5.3B
- IPO Year
- PDI N/A
- ACLX 2022
- Fundamental
- Price
- PDI $19.25
- ACLX $90.44
- Analyst Decision
- PDI
- ACLX Strong Buy
- Analyst Count
- PDI 0
- ACLX 14
- Target Price
- PDI N/A
- ACLX $103.67
- AVG Volume (30 Days)
- PDI 1.5M
- ACLX 647.5K
- Earning Date
- PDI 01-01-0001
- ACLX 11-07-2024
- Dividend Yield
- PDI 13.81%
- ACLX N/A
- EPS Growth
- PDI N/A
- ACLX N/A
- EPS
- PDI N/A
- ACLX N/A
- Revenue
- PDI N/A
- ACLX $155,818,000.00
- Revenue This Year
- PDI N/A
- ACLX $20.54
- Revenue Next Year
- PDI N/A
- ACLX N/A
- P/E Ratio
- PDI N/A
- ACLX N/A
- Revenue Growth
- PDI N/A
- ACLX 230.33
- 52 Week Low
- PDI $15.45
- ACLX $46.42
- 52 Week High
- PDI $19.60
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- PDI 43.40
- ACLX 50.71
- Support Level
- PDI $18.75
- ACLX $83.69
- Resistance Level
- PDI $20.02
- ACLX $107.37
- Average True Range (ATR)
- PDI 0.16
- ACLX 5.96
- MACD
- PDI -0.01
- ACLX -1.27
- Stochastic Oscillator
- PDI 45.05
- ACLX 44.25
About PDI PIMCO Dynamic Income Fund
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investments include mortgage-backed securities, investment grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.